These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
654 related articles for article (PubMed ID: 34368114)
1. Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures. Huo C; Zhang MY; Li R; Liu TT; Li JP; Qu YQ Front Cell Dev Biol; 2021; 9():645482. PubMed ID: 34368114 [TBL] [Abstract][Full Text] [Related]
2. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma. Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739 [TBL] [Abstract][Full Text] [Related]
3. A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with Fu J; Li Y; Li C; Tong Y; Li M; Cang S Transl Cancer Res; 2021 Sep; 10(9):3963-3978. PubMed ID: 35116695 [TBL] [Abstract][Full Text] [Related]
4. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma. Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340 [TBL] [Abstract][Full Text] [Related]
5. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
6. CD1B is a Potential Prognostic Biomarker Associated with Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Adenocarcinoma. Li Z; Feng Y; Li P; Wang S; Liu X; Xia S Int J Gen Med; 2022; 15():3809-3826. PubMed ID: 35418778 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia-related gene signature for predicting LUAD patients' prognosis and immune microenvironment. Chen J; Fu Y; Hu J; He J Cytokine; 2022 Apr; 152():155820. PubMed ID: 35176657 [TBL] [Abstract][Full Text] [Related]
8. Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma. Li L; Li J Front Oncol; 2023; 13():1128785. PubMed ID: 36959799 [TBL] [Abstract][Full Text] [Related]
9. Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma. Liu L; Xu S; Huang L; He J; Liu G; Ma S; Weng Y; Huang S Transl Cancer Res; 2021 Jun; 10(6):2859-2872. PubMed ID: 35116596 [TBL] [Abstract][Full Text] [Related]
11. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma. Zhang C; Li Z; Qi F; Hu X; Luo J Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049 [TBL] [Abstract][Full Text] [Related]
12. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma. Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203 [No Abstract] [Full Text] [Related]
13. Overexpression and diagnostic significance of INTS7 in lung adenocarcinoma and its effects on tumor microenvironment. Li X; Yao Y; Qian J; Jin G; Zeng G; Zhao H Int Immunopharmacol; 2021 Dec; 101(Pt B):108346. PubMed ID: 34781123 [TBL] [Abstract][Full Text] [Related]
14. Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma. Zhang MY; Huo C; Liu JY; Shi ZE; Zhang WD; Qu JJ; Yue YL; Qu YQ Front Cell Dev Biol; 2021; 9():756911. PubMed ID: 34869345 [No Abstract] [Full Text] [Related]
15. [Mutational Signatures Analysis of Micropapillary Components and Exploration of ZNF469 Gene in Early-stage Lung Adenocarcinoma with Ground-glass Opacities]. Xu Y; Sun Q; Wang S; Zhu H; Dong G; Meng F; Xia Z; You J; Kong X; Wu J; Chen P; Yuan F; Yu X; Ji J; Li Z; Zhu P; Sun Y; Liu T; Yin R; Xu L Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):889-900. PubMed ID: 38151328 [TBL] [Abstract][Full Text] [Related]
16. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma. Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573 [TBL] [Abstract][Full Text] [Related]
17. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma. Xu ZY; Zhao M; Chen W; Li K; Qin F; Xiang WW; Sun Y; Wei J; Yuan LQ; Li SK; Lin SH PeerJ; 2020; 8():e9530. PubMed ID: 32775050 [TBL] [Abstract][Full Text] [Related]
18. Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors. Wen Y; Lin A; Zhu W; Wei T; Luo P; Guo L; Zhang J Front Pharmacol; 2021; 12():645862. PubMed ID: 34163353 [No Abstract] [Full Text] [Related]
19. Identifying Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W PeerJ; 2023; 11():e16618. PubMed ID: 38099311 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study. Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]